Prevalence of erectile dysfunction among middle-aged men in a metropolitan area in Germany

Englert, H.; Schaefer, Gerard A.; Roll, Stephanie; Ahlers, Christoph J.; Beier, Klaus M.; Willich, S N

doi:10.1038/sj.ijir.3901510

Cited by 22 publications

(27 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…(IIEF items 13 and 14, response scales ranged from 1 = "very dissatisfied" to 5 = "very satisfied"). Moreover, worry about sexual and relationship functioning (three items; Cronbach's a = 0.85) was constructed using three items from the "Berlin Male Study" [19] (items were: "have you been worried to burden your relationship due to too weak erections during the last 4 weeks? "; "have you been worried about the rigidity of your erection during the past 4 weeks?…”

Section: Methodsmentioning

confidence: 99%

“…Ten thousand community-dwelling men of different age groups (18-79 years) who lived in a midsized town in the eastern part of Germany were randomly chosen. The initial sample's age distribution was designed to reflect the age distribution of this eastern German town (18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29) total N contacted = 10,000). Subjects were asked to complete a 35-item questionnaire, which was mailed to their homes.…”

Section: Study Design and Questionnairementioning

confidence: 99%

“…Likely for methodological differences, results from surveys indicate a large variation in the prevalence of ED ranging between 15% and 50% [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19]. In Germany, recent data point to 19-48% men affected [4,19].…”

Section: Introductionmentioning

confidence: 98%

See 2 more Smart Citations

Worry, Desire, and Sexual Satisfaction and Their Association with Severity of ED and Age

Gralla

Knoll

et al. 2008

The Journal of Sexual Medicine

View full text Add to dashboard Cite

Introduction This study evaluates worry about sexual and relationship functioning, sexual desire, and sexual satisfaction as indicators of sexual quality of life in men of different age groups suffering from mild to severe erectile dysfunction (ED). Aim To increase insight in the mechanisms of some key indicators of sexual quality of life in different age groups. Methods The study sample consisted of 904 men with mild to severe ED. Mean age was 60.7 years (standard deviation [SD] = 12.4) and mean erectile function (EF) (International Index of Erectile Function [IIEF]) score was 14.5 (SD = 8.9). Multivariate analyses of variance were conducted to test the differences in outcomes among two age groups (65 ≤ age > 65) and two levels of ED (16 ≤ EF > 16). Main Outcome Measures We analyzed age, severity of ED, and interrelated indicators of sexual quality of life as worry about sexual or relationship functioning, sexual desire, and overall sexual satisfaction. Beyond, we aimed to see on which of these measures their interaction had specific independent effects. Results Younger men at a higher level of ED reported higher levels of worry about sexual and relationship functioning than older men with high ED. Older men reported slightly less sexual desire than younger men; also, more ED was associated with lower sexual desire. Finally, men with less severe ED reported higher sexual satisfaction than men with more severe ED, whereas at all levels of ED severity, older men reported more sexual satisfaction than younger men. Conclusions Indicators of sexual quality of life among men with ED are poorer in those with more severe ED. However, younger men with severe ED worries concerning sexual functioning were more pronounced than among their older counterparts. Independent of the degree of severity of ED, older men indicated lower sexual desire but higher overall sexual satisfaction. Observed age-group differences were very small, however.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Study Design and Questionnairementioning

confidence: 99%

See 1 more Smart Citation

Worry, Desire, and Sexual Satisfaction and Their Association with Severity of ED and Age

Gralla

Knoll

et al. 2008

The Journal of Sexual Medicine

View full text Add to dashboard Cite

show abstract

“…In the last five decades, there was a significant increase in the number of individuals with erectile dysfunction complaints (24), thus increasing the interest in efficient treatments for improving this condition. Studies with testosterone have had conflicting results iconcerning this topic.…”

Section: Discussionmentioning

confidence: 99%

Short term testosterone replacement therapy improves libido and body composition

Júnior¹,

Clapauch²,

Buksman

2009

Arq Bras Endocrinol Metab

View full text Add to dashboard Cite

Objective: To assess the efficacy and safety of testosterone replacement in males with late-onset hypogonadism compared to hypogonadal men without replacement, and controls, during six months. Methods: We assessed, through ADAM, AMS, IIEF-5 and SF-36 questionnaires, and through clinical and laboratorial examinations, 62 patients divided into three groups: 17 hypogonadal males (HR) used intramuscular testosterone every three weeks; 14 hypogonadal males (HV) and 31 non-hypogonadal males (CV) used oral vitamins daily. Results: When compared to others, HR group obtained libido improvement assessed by ADAM 1 (p = 0.004), and borderline sexual potency improvement assessed by IIEF-5 (p = 0.053), besides a decrease in waist circumference after eight weeks (p = 0.018). The remaining parameters did not differ between the groups. PSA and hematocrit remained stable in those using testosterone. Conclusion: Six months of testosterone replacement improved sexuality and body composition, with prostatic and hematological safety. KeywordsTestosterone replacement therapy; late onset hypogonadism; andropause; libido; body composition; waist circumference resumo Objetivo: Avaliar a eficácia e a segurança da reposição de testosterona em homens com hipogonadismo tardio comparados a hipogonádicos sem reposição e controles, durante seis meses. Métodos: Mediante os questionários ADAM, AMS, IIEF-5 e SF-36, foram feitos exame clínico e laboratorial em 62 pacientes divididos em três grupos: 17 hipogonádicos (HR) usaram testosterona intramuscular a cada três semanas; 14 hipogonádicos (HV) e 31 não hipogonádi-cos (CV) usaram vitaminas via oral diariamente. Resultados: Comparado aos demais, o grupo HR obteve melhora da libido avaliada pelo ADAM 1 (p = 0,004) e melhora limítrofe da potência sexual avaliada pelo IIEF-5 (p = 0.053), além de diminuição da cintura a partir da oitava semana (p = 0,018). Os demais parâmetros não foram diferentes entre os grupos. PSA e hematócrito se mantiveram estáveis nos que usaram testosterona. Conclusão: A reposição de testosterona durante seis meses melhorou a sexualidade e a composição corporal, com segurança prostática e hematológica. Arq Bras Endocrinol Metab. 2009;53(8):996-1004 Descritores

show abstract

“…In the United States more than 30 million men have ED and in Germany the age-adjusted ED prevalence rates are estimated to be between 18 and 48% [8]. A 2003 survey of 4,539 Canadian men aged 40 years and older and involved in a heterosexual relationship found that 34% of respondents had ED [9].…”

Section: Introductionmentioning

confidence: 99%

Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reference men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P)

et al. 2009

View full text Add to dashboard Cite

BackgroundThe PORPUS-P is a short questionnaire for measuring prostate-specific quality of life (QoL), which was designed in Canada for use in prostate cancer (PC) patients. We aimed to generate a German version and compare PORPUS-P scores of German reference men from the general population, and German and Canadian patients with newly diagnosed PC who were scheduled to receive radical prostatectomy (RP) or radiotherapy (RT).MethodsThe study sample consisted of 988 reference men, 121 German and 66 Canadian PC patients scheduled for RT, and 371 German and 68 Canadian PC patients scheduled for RP. All men completed the PORPUS-P (German postal questionnaire, Canada personal interview). Data were gathered from PC patients before the start of therapy.ResultsCanadian patients were better educated than the German patients, and fewer were retired. Patients scheduled to receive RT were older and more were retired. German RT patients had lower D'Amico risk scores and pre-treatment Gleason scores than RP patients, and Canadian RT patients had higher pre-treatment PSA than RP patients. Urinary and sexual dysfunction were seen in PC patients (especially RT patients), but were also common in the German reference men. Crude mean PORPUS-P scores differed statistically significant between German RT and RP and Canadian RP and RT patients, with RT patients having higher QoL scores. The differences in age-adjusted mean PORPUS-P scores between reference men and RP patients were not clinically significant, while RT patients had (clinically) significantly lower scores than the reference men.ConclusionThe German translation of the PORPUS-P appears to be a short and feasible tool for assessing prostate-specific QoL. Although we found a similar response pattern, Canadian and German PC patients scheduled to receive RT or RP rated their pre-treatment quality of life on different levels, which reveals the need for national reference data. Problems in several QoL domains exist before treatment, and differ between PC patients scheduled for RT and RP.

show abstract

Prevalence of erectile dysfunction among middle-aged men in a metropolitan area in Germany

Cited by 22 publications

References 27 publications

Worry, Desire, and Sexual Satisfaction and Their Association with Severity of ED and Age

Worry, Desire, and Sexual Satisfaction and Their Association with Severity of ED and Age

Short term testosterone replacement therapy improves libido and body composition

Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reference men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P)

Contact Info

Product

Resources

About